Summary
Cooper Companies to Post Q1 Earnings: Is a Beat in the Offing?
COO heads into Q1 earnings with revenue seen up 6.3% and EPS up 12%, as lens growth and cost savings face mix and tariff headwinds.
What Analyst Projections for Key Metrics Reveal About The Cooper Companies (COO) Q1 Earnings
Get a deeper insight into the potential performance of The Cooper Companies (COO) for the quarter ended January 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy?
The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Corum Group Ltd (COO) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Corum Group Ltd ever had a stock split?
Corum Group Ltd Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Albert G. White CEO | ASX Exchange | AU000000COO1 ISIN |
| US Country | 16,000 Employees | 26 Jul 2023 Last Dividend | 20 Feb 2024 Last Split | - IPO Date |
Overview
The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global entity that specializes in the development, manufacture, and marketing of contact lenses through its subsidiaries. The operations of the company are segmented into CooperVision and CooperSurgical. CooperVision focuses on providing a variety of contact lenses including those for correcting nearsightedness, farsightedness, astigmatism, presbyopia, and myopia across various regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical addresses family and women's health, offering a wide range of fertility products and services, medical devices, contraception, and cryostorage services for cord blood and tissue to healthcare professionals and patients globally. The products offered by The Cooper Companies, Inc. reach their end-users through distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals, clinics, and authorized resellers.
Products and Services
CooperVision:
- Spherical Lenses: These lenses are designed to correct common vision problems such as nearsightedness and farsightedness.
- Toric and Multifocal Lenses: These lenses provide solutions for more complex vision challenges, including astigmatism, presbyopia, and myopia, catering to a diverse range of contact lens wearers.
CooperSurgical:
- Fertility Products and Services: Includes consumables, equipment, donor gamete services, and genomic services such as genetic testing, designed to support the varying needs of fertility treatments.
- Medical Devices and Contraception: Ranging from Paragard contraceptive IUDs, endosee endometrial imaging, and Mara water ablation systems, these products aim to provide innovative solutions in women's healthcare and family planning.
- Cryostorage Services: Offering storage solutions for cord blood and tissue, these services play a crucial role in regenerative medicine and future health considerations.
- Surgical and Office Products: This encompasses a broad spectrum of devices and tools such as illuminated speculum products, lone star retractor systems, and fetal pillow cephalic elevation devices, used across gynecological procedures and office-based diagnostics.
